|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||69.08 - 69.08|
|52-week range||40.55 - 102.00|
|Beta (5Y monthly)||0.90|
|PE ratio (TTM)||136.79|
|Forward dividend & yield||0.11 (0.16%)|
|Ex-dividend date||30 Mar 2021|
|1y target est||N/A|
Shape Memory Medical Inc. receives PMDA approval to market its IMPEDE®-FX Embolization Plug in Japan.
Wake Research, an integrated national network of clinical investigative sites and one of North America's leading providers of Phase I-IV clinical trials, was recognized as a Top Enroller of patient volunteers by Novavax, a Maryland-based biotechnology firm, in their COVID-19 Phase III vaccine clinical trial. Since hosting the official commencement of Operation Warp Speed with Vice President Mike Pence during his visit to the Research Triangle in 2020, Wake Research has helped lead the nation's efforts to provide high-quality trial data on COVID vaccines to help several vaccines get the greenlight from the FDA.
After more than nine years providing marketing and recruiting services for thousands of clinical research trials, RMA is launching a new website and expanding its services to other clinical research companies nationwide.